{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:17:05Z","timestamp":1768425425437,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.reprotox.2006.03.019","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T17:01:05Z","timestamp":1150131665000},"page":"571-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials"],"prefix":"10.1016","volume":"22","author":[{"given":"Roja","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekoufeh","family":"Nikfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 15","key":"10.1016\/j.reprotox.2006.03.019_bib1","first-page":"26","article-title":"Depression during pregnancy and the puerperium","volume":"58","author":"Llewellyn","year":"1997","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.reprotox.2006.03.019_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00002018-200528020-00005","article-title":"The safety of newer antidepressants in pregnancy and breastfeeding","volume":"28","author":"Gentile","year":"2005","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.reprotox.2006.03.019_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.jcp.0000150228.61501.e4","article-title":"The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects","volume":"25","author":"Hallberg","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"3 Pt 1","key":"10.1016\/j.reprotox.2006.03.019_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0368-2315(05)82745-0","article-title":"Depressive syndromes during pregnancy: prevalence and risk factors","volume":"34","author":"Lteif","year":"2005","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.reprotox.2006.03.019_bib5","doi-asserted-by":"crossref","unstructured":"Berle JO, et al. Neonatal outcomes in offspring of women with anxiety and depression during pregnancy. A linkage study from The Nord-Trondelag Health Study (HUNT) and Medical Birth Registry of Norway. Arch Women Ment Health. 2005; 8(3):181\u2013189.","DOI":"10.1007\/s00737-005-0090-z"},{"key":"10.1016\/j.reprotox.2006.03.019_bib6","first-page":"1087","article-title":"Depression during pregnancy","volume":"51","author":"Ryan","year":"2005","journal-title":"Can Fam Physician"},{"issue":"9","key":"10.1016\/j.reprotox.2006.03.019_bib7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archpsyc.61.9.946","article-title":"Impact of maternal depression on infant nutritional status and illness: a cohort study","volume":"61","author":"Rahman","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.reprotox.2006.03.019_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.epirev.a036172","article-title":"Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings","volume":"17","author":"Orr","year":"1995","journal-title":"Epidemiol Rev"},{"issue":"9","key":"10.1016\/j.reprotox.2006.03.019_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/aje\/kwf131","article-title":"Maternal prenatal depressive symptoms and spontaneous preterm births among African\u2013American women in Baltimore","volume":"156","author":"Orr","year":"2002","journal-title":"Maryland Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.reprotox.2006.03.019_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00006842-200109000-00017","article-title":"Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes","volume":"63","author":"Chung","year":"2001","journal-title":"Psychosom Med"},{"issue":"9458","key":"10.1016\/j.reprotox.2006.03.019_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.reprotox.2006.03.019_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/080352501300067596","article-title":"Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors","volume":"90","author":"Nordeng","year":"2001","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.reprotox.2006.03.019_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/10454411000110020601","article-title":"The role of serotonin and neurotransmitters during craniofacial development","volume":"11","author":"Moiseiwitsch","year":"2000","journal-title":"Crit Rev Oral Biol Med"},{"issue":"14","key":"10.1016\/j.reprotox.2006.03.019_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"issue":"5 Pt 1","key":"10.1016\/j.reprotox.2006.03.019_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0029-7844(97)00070-7","article-title":"Effects of first-trimester fluoxetine exposure on the newborn","volume":"89","author":"Goldstein","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.reprotox.2006.03.019_bib16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of children exposed in utero to antidepressant drugs","volume":"336","author":"Nulman","year":"1997","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.reprotox.2006.03.019_bib17","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.1993.03500170076037","article-title":"Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac)","volume":"269","author":"Pastuszak","year":"1993","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.reprotox.2006.03.019_bib18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","article-title":"Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study","volume":"279","author":"Kulin","year":"1998","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.reprotox.2006.03.019_bib19","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1176\/appi.ajp.158.10.1728","article-title":"Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study","volume":"158","author":"Einarson","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.reprotox.2006.03.019_bib20","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure","volume":"159","author":"Simon","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.reprotox.2006.03.019_bib21","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1067\/mob.2003.172","article-title":"Birth outcomes after prenatal exposure to antidepressant medication","volume":"188","author":"Hendrick","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.reprotox.2006.03.019_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","article-title":"Perinatal outcome following third trimester exposure to paroxetine","volume":"156","author":"Costei","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.reprotox.2006.03.019_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0890-6238(96)00057-3","article-title":"The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS)","volume":"10","author":"McElhatton","year":"1996","journal-title":"Reprod Toxicol"},{"issue":"7","key":"10.1016\/j.reprotox.2006.03.019_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002280050664","article-title":"Delivery outcome after the use of antidepressants in early pregnancy","volume":"55","author":"Ericson","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.reprotox.2006.03.019_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"Casper","year":"2003","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.reprotox.2006.03.019_bib26","first-page":"298","article-title":"Pregnancy outcome after gestational exposure to paroxetine: a prospective controlled study cohort [abstract]","volume":"65","author":"Diav-Citrin","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2006.03.019_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00737-004-0057-5","article-title":"The impact of depression and fluoxetine treatment on obstetrical outcome","volume":"7","author":"Suri","year":"2004","journal-title":"Arch Womens Ment Health"},{"issue":"2","key":"10.1016\/j.reprotox.2006.03.019_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0028-2243(79)90003-0","article-title":"5-Hydroxytryptamine (serotonin), copper and ceruloplasmin plasma concentrations in spontaneous abortion","volume":"9","author":"Bassiouni","year":"1979","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"12","key":"10.1016\/j.reprotox.2006.03.019_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/pds.1084","article-title":"Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies","volume":"14","author":"Einarson","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.reprotox.2006.03.019_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1345\/aph.1E547","article-title":"Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis","volume":"39","author":"Hemels","year":"2005","journal-title":"Ann Pharmacother"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623806000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623806000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:52Z","timestamp":1760189092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623806000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0890623806000992"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.03.019","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2006.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}